Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 18.74M
March 31, 2026 35.00M
December 31, 2025 2.998M
September 30, 2025 3.458M
June 30, 2025 9.534M
March 31, 2025 18.49M
December 31, 2024 40.44M
September 30, 2024 44.78M
June 30, 2024 93.72M
March 31, 2024 52.86M
December 31, 2023 76.11M
September 30, 2023 106.30M
June 30, 2023 157.85M
March 31, 2023 189.23M
December 31, 2022 193.36M
September 30, 2022 218.23M
June 30, 2022 238.33M
March 31, 2022 262.69M
December 31, 2021 306.92M
September 30, 2021 261.53M
June 30, 2021 73.54M
March 31, 2021 119.37M
December 31, 2020 99.87M
September 30, 2020 114.14M
June 30, 2020 79.17M
Date Value
March 31, 2020 92.28M
December 31, 2019 61.81M
September 30, 2019 93.27M
June 30, 2019 121.72M
March 31, 2019 158.31M
December 31, 2018 53.05M
September 30, 2018 46.17M
June 30, 2018 43.16M
March 31, 2018 52.35M
December 31, 2017 60.19M
September 30, 2017 70.05M
June 30, 2017 96.77M
March 31, 2017 123.82M
December 31, 2016 76.44M
September 30, 2016 95.40M
June 30, 2016 123.29M
March 31, 2016 148.23M
December 31, 2015 171.67M
September 30, 2015 199.13M
June 30, 2015 139.64M
March 31, 2015 79.30M
December 31, 2014 40.22M
September 30, 2014 52.91M
June 30, 2014 62.82M
March 31, 2014 73.49M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Novavax, Inc. 719.34M
Amgen, Inc. 13.99B
Anika Therapeutics, Inc. 38.41M
BioCryst Pharmaceuticals, Inc. 353.05M
Imunon, Inc. 6.864M